ENvue Medical, Inc. (FEED) Form S-3 — Aug 10, 2026
ENvue Medical (FEED), the medical device company formerly known as NanoVibronix, filed a Form S-3 universal shelf registration on August 10, 2026 to sell up to $50,000,000 of common stock, warrants and units from time to time, with proceeds earmarked for manufacturing, commercial sales and marketing, R&D, M&A, and general working capital. The shelf comes with a serious listing overhang: the filing discloses that Nasdaq's Staff determined on July 10, 2026 to delist FEED after the stock closed below $1.00 for 30 consecutive business days, and the company is not eligible for the standard 180-day cure period because it already executed a 1-for-10 reverse split on August 12, 2025.
Key figures
- Gross Proceeds
- up to $50,000,000 aggregate
- Shares Outstanding
- 9296667
- Public float
- $7,261,689 (8,251,920 non-affiliate shares at $0.88 as of June 11, 2026)
- Shelf size usd
- 50000000
- Baby shelf limit
- primary offerings capped at one-third of public float per 12 months while float below $75.0 million
- Reverse split history
- 1-for-10 reverse stock split effected August 12, 2025
- Minimum bid deficiency
- closing bid below $1.00 for 30 consecutive business days
- Total offering expenses
- $43,405 (including $6,905 registration fee)
- Last reported sale price
- $0.40 (August 7, 2026)
- Series g preferred outstanding
- 820 shares convertible into 14,573 common shares
- Series h preferred outstanding
- 11,246 shares convertible into 27,947,321 common shares
- Series x preferred outstanding
- 47,592 shares convertible into 1,414,644 common shares
- Securities sold prior 12 months
- $1,532,906
Price after filing
Close on the filing date to close N calendar days later (from $4.97). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.